The candidate would be the first to put oxycodone and morphine in one capsule.
AbbVie's all-oral HCV treatment filed off six Phase-III trials spanning 25 countries and 2,300 patients
Ramucirumab received FDA approval today in advanced gastric cancer, a nod that could translate into $600 million in peak sales.
The three drugmakers rearranged part of the pharma universe Tuesday with a string of pipeline-altering deals.
The deal would bring Allergan's Botox and Juvederm under the same roof as Restylane.
The rumored $101 billion bid would give Pfizer a foothold in imuno-oncology and diabetes.
Officials are asking users to change passwords, as an added precaution.
Physicians tell Leerink most of their patients are receiving the drug. Rejections tend to be over off-label use.
The company said it plans to file its rare-disease drug with the FDA later this year, for a 2015 review.
The Supreme Court denied Teva's request to keep branded Copaxone off the market while the appeals process shakes out.